Hail First Pharma Inc.
Hail First Pharma Inc.: Trading Halted Pending Reverse Split
Hail First Pharma Inc. / Key word(s): Corporate Action Hail First Pharma Trading Halted Pending Reverse Split Dubai – UAE – May 4, 2011 – Hail First Pharma Inc. formerly Zoloto Ventures Corp. (Frankfurt: 499) Announced today that the Deutsche Börse has halted trading pending the reverse split. The name change has taken effect on April 26, 2011 and the reverse stock split is expected to take effect the week of May 6, 2011 pending receipt of a new ISIN number reflecting the corporate action. The company’s share will resume trading upon the effectiveness of the reverse stock split of 10,000 to 1. About Hail First Pharma Hail First Pharma is a pharmaceutical company specializing in acquiring, licensing and distributing of diabetic drugs, drug delivery technology, nutritional products and medical equipment. Important Information Contact: Hussain Al-Awaid Robert Albi End of Corporate News 04.05.2011 Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de |
123027 04.05.2011 |